Vascular damage in kidney disease: Beyond hypertension

International Journal of Hypertension

Volumn 2011, Issue , 2011, Pages

  Stinghen, Andréa E M ^a   Pecoits Filho, Roberto ^b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BETA 2 MICROGLOBULIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTOXIN; HOMOCYSTEINE; INDOLE DERIVATIVE; INTERLEUKIN 8; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PARATHYROID HORMONE; PHENOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; UREA; URIC ACID; VASCULAR CELL ADHESION MOLECULE 1;

ALMS1 GENE; APOE GENE; ATHEROSCLEROSIS; BIOACCUMULATION; BLOOD VESSEL INJURY; BTG2 GENE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEBPD GENE; CHRONIC KIDNEY DISEASE; CXCL12 GENE; CXCR4 GENE; DISEASE ASSOCIATION; DNA METHYLATION; DOWN REGULATION; ENDOTHELIAL DYSFUNCTION; EPIGENETICS; ESTROGEN RECEPTOR ALPHA GENE; GADD45A GENE; GCKR GENE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE SILENCING; GENETIC RISK; GENETIC VARIABILITY; GENOMICS; GENOTYPE ENVIRONMENT INTERACTION; HISTONE MODIFICATION; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; IL8R GENE; INFLAMMATION; LASS2 GENE; MIF GENE; OXIDATIVE STRESS; PDE4B GENE; PRIORITY JOURNAL; PRKAG2 GENE; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; SLC34A1 GENE; SLC7A9 GENE; TOB1 GENE; UPREGULATION; UREMIA; VASCULAR ENDOTHELIUM; VEGFA GENE;

EID: 84857634081     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2011/232683     Document Type: Review

References (45)

1. El Nahas M., Cardio-kidney-damage: a unifying concept. Kidney International 2010 78 1 14 18 2-s2.0-77953686335 10.1038/ki.2010.123
2. House A. A., Haapio M., Lassus J., Bellomo R., Ronco C., Therapeutic strategies for heart failure in cardiorenal syndromes. American Journal of Kidney Diseases 2010 56 4 759 773 2-s2.0-77956902834 10.1053/j.ajkd.2010.04.012
3. Stenvinkel P., Carrero J. J., Axelsson J., Lindholm B., Heimburger O., Massy Z., Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clinical Journal of the American Society of Nephrology 2008 3 2 505 521 2-s2.0-42549131781 10.2215/CJN.03670807
4. Stenvinkel P., Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. Journal of Internal Medicine 2010 268 5 456 467 2-s2.0-77958600480 10.1111/j.1365-2796.2010.02269.x
5. Meijers B. K., Claes K., Bammens B., De Loor H., Viaene L., Verbeke K., Kuypers D., Vanrenterghem Y., Evenepoel P., p and cardiovascular risk in mild-to-moderate kidney disease. Clinical Journal of the American Society of Nephrology 2010 5 7 1182 1189 2-s2.0-77954793132 10.2215/CJN.07971109
6. Glassock R. J., Uremic toxins: what are they? An integrated overview of pathobiology and classification. Journal of Renal Nutrition 2008 18 1 2 6 2-s2.0-37049004490 10.1053/j.jrn.2007.10.003 (Pubitemid 350251821)
7. Himmelfarb J., Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Seminars in Dialysis 2009 22 6 636 643 2-s2.0-71549120440 10.1111/j.1525-139X.2009.00659.x
8. Vanholder R., Van Laecke S., Glorieux G., What is new in uremic toxicity? Pediatric Nephrology 2008 23 8 1211 1221 2-s2.0-46949111224 10.1007/s00467-008-0762-9
9. Vanholder R., De Smet R., Glorieux G., Argiles A., Baurmeister U., Brunet P., Clark W., Cohen G., De Deyn P. P., Deppisch R., Descamps-Latscha B., Henle T., Lemke H. D., Massy Z. A., Passlick-Deetjen J., Rodriguez M., Stegmayr B., Stenvinkel P., Tetta C., Wanner C., Zidek W., Review on uremic toxins: classification, concentration, and interindividual variability. Kidney International 2003 63 5 1934 1943 2-s2.0-0037406406 10.1046/j.1523-1755.2003. 00924.x (Pubitemid 36513344)
10. Vanholder R., Argiles A., Baurmeister U., Brunet P., Clark W., Cohen G., De Deyn P. P., Deppisch R., Descamps-Latscha B., Henle T., Massy Z. A., Rodriguez M., Stegmayr B., Stenvinkel P., Wratten M. L., Uremic toxicity: present state of the art. International Journal of Artificial Organs 2001 24 10 695 725 2-s2.0-0035199052 (Pubitemid 33121206)
11. Malyszko J., Mechanism of endothelial dysfunction in chronic kidney disease. Clinica Chimica Acta 2010 411 19-20 1412 1420 2-s2.0-77955052030 10.1016/j.cca.2010.06.019
12. Fliser D., Perspectives in renal disease progression: the endothelium as a treatment target in chronic kidney disease. Journal of Nephrology 2010 23 4 369 376 2-s2.0-77955457090
13. Cohen G., Glorieux G., Thornalley P., Schepers E., Meert N., Jankowski J., Jankowski V., Argiles A., Anderstam B., Brunet P., Cerini C., Dou L., Deppisch R., Marescau B., Massy Z., Perna A., Raupachova J., Rodriguez M., Stegmayr B., Vanholder R., Hörl W. H., Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro towards a standardized approach for research on uraemia. Nephrology Dialysis Transplantation 2007 22 12 3381 3390 2-s2.0-36749019207 10.1093/ndt/gfm210 (Pubitemid 350212473)
14. Segal M. S., Baylis C., Johnson R. J., Endothelial health and diversity in the kidney. Journal of the American Society of Nephrology 2006 17 2 323 324 2-s2.0-33645458114 10.1681/ASN.2005121296
15. Diaz-Buxo J. A., Woods H. F., Protecting the endothelium: a new focus for management of chronic kidney disease. Hemodialysis International 2006 10 1 42 48 2-s2.0-33144477390 10.1111/j.1542-4758.2006.01173.x (Pubitemid 43263290)
16. Dou L., Jourde-Chiche N., Faure V., Cerini C., Berland Y., Dignat-George F., Brunet P., The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. Journal of Thrombosis and Haemostasis 2007 5 6 1302 1308 2-s2.0-34250163587 10.1111/j.1538-7836.2007.02540.x (Pubitemid 46902134)
17. Bro S., Bentzon J. F., Falk E., Andersen C. B., Olgaard K., Nielsen L. B., Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. Journal of the American Society of Nephrology 2003 14 10 2466 2474 2-s2.0-0141455349 10.1097/01.ASN.0000088024.72216.2E (Pubitemid 37169332)
18. Buzello M., Törnig J., Faulhaber J., Ehmke H., Ritz E., Amann K., The apolipoprotein E knockout mouse: a model documenting accelerated atherogenesis in uremia. Journal of the American Society of Nephrology 2003 14 2 311 316 2-s2.0-0037306239 10.1097/01.ASN.0000045048.71975.FC (Pubitemid 36150854)
19. Brunet P., Gondouin B., Duval-Sabatier A., Dou L., Cerini C., Dignat-George F., Does uremia cause vascular dysfunction? Kidney and Blood Pressure Research 2011 34 4 284 290
20. Zieman S., Kass D., Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease. Congestive Heart Failure 2004 10 3 144 151 2-s2.0-4344632810
21. Vanhoutte P. M., Feletou M., Taddei S., Endothelium-dependent contractions in hypertension. British Journal of Pharmacology 2005 144 4 449 458 2-s2.0-14844320534 10.1038/sj.bjp.0706042 (Pubitemid 40349452)
22. Fliser D., Kronenberg F., Kielstein J. T., Morath C., Bode-Boger S. M., Haller H., Ritz E., Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. Journal of the American Society of Nephrology 2005 16 8 2456 2461 2-s2.0-27444444747 10.1681/ASN.2005020179 (Pubitemid 41725064)
23. Boger R. H., Bode-Boger S. M., Sydow K., Heistad D. D., Lentz S. R., Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 6 1557 1564 (Pubitemid 30353888)
24. Vanholder R., Baurmeister U., Brunet P., Cohen G., Glorieux G., Jankowski J., A bench to bedside view of uremic toxins. Journal of the American Society of Nephrology 2008 19 5 863 870 2-s2.0-44049106323 10.1681/ASN.2007121377
25. Vanholder R., van Laecke S., Glorieux G., The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity? Journal of Nephrology 2008 21 2 146 160 2-s2.0-48849087575
26. Stubbs J. R., Wetmore J. B., Does it matter how parathyroid hormone levels are suppressed in secondary hyperparathyroidism? Seminars in Dialysis 2011 24 3 298 306
27. Neves K. R., Graciolli F. G., dos Reis L. M., Graciolli R. G., Neves C. L., Batista D. G., Jorgetti V., Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney International 2007 71 12 1262 1270 2-s2.0-34250028426 10.1038/sj.ki.5002241 (Pubitemid 46884255)
28. Stinghen A. E., Goncalves S. M., Martines E. G., Nakao L. S., Riella M. C., Aita C. A., Pecoits-Filho R., Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease. Nephron Clinical Practice 2009 111 2 c117 c126 2-s2.0-58149510772 10.1159/000191205
29. Hauser A. B., Azevedo I. R., Goncalves S., Stinghen A., Aita C., Pecoits-Filho R., Sevelamer carbonate reduces inflammation and endotoxemia in an animal model of uremia. Blood Purification 2010 30 3 153 158 2-s2.0-77956855146 10.1159/000319850
30. Goncalves S., Pecoits-Filho R., Perreto S., Barberato S. H., Stinghen A. E. M., Lima E. G. A., Fuerbringer R., Sauthier S. M., Riella M. C., Associations between renal function, volume status and endotoxaemia in chronic kidney disease patients. Nephrology Dialysis Transplantation 2006 21 10 2788 2794 2-s2.0-33749631245 10.1093/ndt/gfl273 (Pubitemid 44542232)
31. Aline B., Hauser A. E. M. S., Simone M. G., Bucharles S., Pecoits-Filho R., A gut feeling on endotoxemia: causes and consequences in chronic kidney disease. Nephron Clinical Practice 2010 118 2 c165 c172 2-s2.0-78650056769 10.1159/000321438
32. Gunthner T., Jankowski V., Kretschmer A., Nierhaus M., van der Giet M., Zidek W., Jankowski J., Endothelium and vascular smooth muscle cells in the context of uremia. Seminars in Dialysis 2009 22 4 428 432 2-s2.0-69249104918 10.1111/j.1525-139X.2009.00594.x
33. Stenvinkel P., Ekstrom T. J., Epigeneticsa helpful tool to better understand processes in clinical nephrology? Nephrology Dialysis Transplantation 2008 23 5 1493 1496 2-s2.0-43849095576 10.1093/ndt/gfn056 (Pubitemid 351767797)
34. Stenvinkel P., Karimi M., Johansson S., Axelsson J., Suliman M., Lindholm B., Barany P., Alvestrand A., Nordfors L., Qureshi A. R., Ekstrom T. J., Schalling M., Impact of inflammation on epigenetic DNA methylationa novel risk factor for cardiovascular disease? Journal of Internal Medicine 2007 261 5 488 499 2-s2.0-34247145010 10.1111/j.1365-2796.2007.01777.x (Pubitemid 46587721)
35. Ingrosso D., Cimmino A., Perna A. F., Masella L., De Santo N. G., De Bonis M. L., Vacca M., Galletti P., Zappia V., Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. The Lancet 2003 361 9370 1693 1699 2-s2.0-0038663165 10.1016/S0140-6736(03)13372-7 (Pubitemid 36577442)
36. Huang Y. S., Zhi Y. F., Wang S. R., Hypermethylation of estrogen receptor- α gene in atheromatosis patients and its correlation with homocysteine. Pathophysiology 2009 16 4 259 265 2-s2.0-69249217999 10.1016/j.pathophys.2009.02.010
37. Yi-Deng J., Tao S., Hui-Ping Z., Jian-Tuan X., Jun C., Gui-Zhong L., Shu-Ren W., Folate and ApoE DNA methylation induced by homocysteine in human monocytes. DNA and Cell Biology 2007 26 10 737 744 2-s2.0-38449118658 10.1089/dna.2007.0619
38. Zaza G., Pontrelli P., Pertosa G., Granata S., Rossini M., Porreca S., Staal F. J. T., Gesualdo L., Grandaliano G., Schena F. P., Dialysis-related systemic microinflammation is associated with specific genomic patterns. Nephrology Dialysis Transplantation 2008 23 5 1673 1681 2-s2.0-44449158609 10.1093/ndt/gfm804 (Pubitemid 351767731)
39. Karin N., The multiple faces of CXCL12 (SDF-1 α) in the regulation of immunity during health and disease. Journal of Leukocyte Biology 2010 88 3 463 473 2-s2.0-77957157551 10.1189/jlb.0909602
40. Rueda P., Balabanian K., Lagane B., Staropoli I., Chow K., Levoye A., Laguri C., Sadir R., Delaunay T., Izquierdo E., Pablos J. L., Lendinez E., Caruz A., Franco D., Baleux F., Lortat-Jacob H., Arenzana-Seisdedos F., The CXCL12 γ chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins. PLoS ONE 2008 3 7 2-s2.0-49749117434 10.1371/journal.pone.0002543 e2543
41. Barbieri F., Bajetto A., Porcille C., Pattarozzi A., Schettini G., Florio T., Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function. Journal of Molecular Endocrinology 2007 38 3-4 383 389 2-s2.0-34248192431 10.1677/JME-06-0014 (Pubitemid 46723254)
42. Ghadge S., Muhlstedt S., Ozcelik C., Bader M., SDF-1 α as a therapeutic stem cell homing factor in myocardial infarction. Pharmacology & Therapeutics 2011 129 97 108
43. Jie K. E., Zaikova M. A., Bergevoet M. W., Westerweel P. E., Rastmanesh M., Blankestijn P. J., Boer W. H., Braam B., Verhaar M. C., Progenitor cells and vascular function are impaired in patients with chronic kidney disease. Nephrology Dialysis Transplantation 2010 25 6 1875 1882 2-s2.0-77953014670 10.1093/ndt/gfp749
44. Kottgen A., Genome-wide association studies in nephrology research. American Journal of Kidney Diseases 2010 56 4 743 758 2-s2.0-77956927105 10.1053/j.ajkd.2010.05.018
45. Shah V. O., Dominic E. A., Moseley P., Pickett G., Fleet M., Ness S., Raj D. S. C., Hemodialysis modulates gene expression profile in skeletal muscle. American Journal of Kidney Diseases 2006 48 4 616 628 2-s2.0-33748884516 10.1053/j.ajkd.2006.05.032 (Pubitemid 44425373)